STE
Price
$239.59
Change
+$2.68 (+1.13%)
Updated
Jun 24, 04:59 PM (EDT)
Capitalization
22.22B
47 days until earnings call
XRAY
Price
$15.63
Change
+$0.16 (+1.03%)
Updated
Jun 24, 04:59 PM (EDT)
Capitalization
6.69B
36 days until earnings call
Interact to see
Advertisement

STE vs XRAY

Header iconSTE vs XRAY Comparison
Open Charts STE vs XRAYBanner chart's image
STERIS
Price$239.59
Change+$2.68 (+1.13%)
Volume$5.75K
Capitalization22.22B
DENTSPLY SIRONA
Price$15.63
Change+$0.16 (+1.03%)
Volume$73.74K
Capitalization6.69B
STE vs XRAY Comparison Chart in %
Loading...
STE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XRAY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
STE vs. XRAY commentary
Jun 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is STE is a Hold and XRAY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 25, 2025
Stock price -- (STE: $236.91 vs. XRAY: $15.48)
Brand notoriety: STE and XRAY are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: STE: 64% vs. XRAY: 101%
Market capitalization -- STE: $22.22B vs. XRAY: $6.69B
STE [@Medical Specialties] is valued at $22.22B. XRAY’s [@Medical Specialties] market capitalization is $6.69B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.56B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

STE’s FA Score shows that 1 FA rating(s) are green whileXRAY’s FA Score has 1 green FA rating(s).

  • STE’s FA Score: 1 green, 4 red.
  • XRAY’s FA Score: 1 green, 4 red.
According to our system of comparison, STE is a better buy in the long-term than XRAY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

STE’s TA Score shows that 4 TA indicator(s) are bullish while XRAY’s TA Score has 3 bullish TA indicator(s).

  • STE’s TA Score: 4 bullish, 4 bearish.
  • XRAY’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, STE is a better buy in the short-term than XRAY.

Price Growth

STE (@Medical Specialties) experienced а -1.76% price change this week, while XRAY (@Medical Specialties) price change was -2.82% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +1.18%. For the same industry, the average monthly price growth was +2.06%, and the average quarterly price growth was -0.38%.

Reported Earning Dates

STE is expected to report earnings on Aug 11, 2025.

XRAY is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Medical Specialties (+1.18% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
STE($22.2B) has a higher market cap than XRAY($6.69B). STE has higher P/E ratio than XRAY: STE (38.85) vs XRAY (19.23). STE YTD gains are higher at: 15.821 vs. XRAY (-17.597). STE has higher annual earnings (EBITDA): 1.39B vs. XRAY (249M). XRAY has more cash in the bank: 334M vs. STE (196M). XRAY has less debt than STE: XRAY (2.3B) vs STE (3.51B). STE has higher revenues than XRAY: STE (5.41B) vs XRAY (3.97B).
STEXRAYSTE / XRAY
Capitalization22.2B6.69B332%
EBITDA1.39B249M560%
Gain YTD15.821-17.597-90%
P/E Ratio38.8519.23202%
Revenue5.41B3.97B136%
Total Cash196M334M59%
Total Debt3.51B2.3B153%
FUNDAMENTALS RATINGS
STE vs XRAY: Fundamental Ratings
STE
XRAY
OUTLOOK RATING
1..100
6164
VALUATION
overvalued / fair valued / undervalued
1..100
18
Undervalued
2
Undervalued
PROFIT vs RISK RATING
1..100
42100
SMR RATING
1..100
7097
PRICE GROWTH RATING
1..100
5163
P/E GROWTH RATING
1..100
5487
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

XRAY's Valuation (2) in the Medical Specialties industry is in the same range as STE (18). This means that XRAY’s stock grew similarly to STE’s over the last 12 months.

STE's Profit vs Risk Rating (42) in the Medical Specialties industry is somewhat better than the same rating for XRAY (100). This means that STE’s stock grew somewhat faster than XRAY’s over the last 12 months.

STE's SMR Rating (70) in the Medical Specialties industry is in the same range as XRAY (97). This means that STE’s stock grew similarly to XRAY’s over the last 12 months.

STE's Price Growth Rating (51) in the Medical Specialties industry is in the same range as XRAY (63). This means that STE’s stock grew similarly to XRAY’s over the last 12 months.

STE's P/E Growth Rating (54) in the Medical Specialties industry is somewhat better than the same rating for XRAY (87). This means that STE’s stock grew somewhat faster than XRAY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
STEXRAY
RSI
ODDS (%)
Bearish Trend 2 days ago
51%
Bearish Trend 2 days ago
54%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
60%
Bullish Trend 2 days ago
61%
Momentum
ODDS (%)
Bearish Trend 2 days ago
54%
Bearish Trend 2 days ago
72%
MACD
ODDS (%)
Bearish Trend 2 days ago
44%
Bearish Trend 2 days ago
63%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
53%
Bearish Trend 2 days ago
71%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
50%
Bearish Trend 2 days ago
72%
Advances
ODDS (%)
Bullish Trend 19 days ago
57%
Bullish Trend 15 days ago
58%
Declines
ODDS (%)
Bearish Trend 5 days ago
49%
Bearish Trend 12 days ago
70%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
62%
Bullish Trend 2 days ago
54%
Aroon
ODDS (%)
Bullish Trend 2 days ago
57%
Bearish Trend 2 days ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
STE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XRAY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HGTY10.020.17
+1.73%
Hagerty
EXPE165.820.94
+0.57%
Expedia Group
EVC2.25N/A
N/A
Entravision Communication
MTVA0.67-0.01
-0.89%
MetaVia Inc
BMA69.06-1.35
-1.92%
Banco Macro SA

XRAY and

Correlation & Price change

A.I.dvisor indicates that over the last year, XRAY has been loosely correlated with NVST. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if XRAY jumps, then NVST could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XRAY
1D Price
Change %
XRAY100%
+0.78%
NVST - XRAY
53%
Loosely correlated
+0.05%
QDEL - XRAY
50%
Loosely correlated
-2.40%
ALGN - XRAY
49%
Loosely correlated
+0.90%
STE - XRAY
47%
Loosely correlated
+0.53%
KIDS - XRAY
46%
Loosely correlated
+1.48%
More